Khosla Ventures
Khosla Ventures is a California-based venture capital firm founded in 2004 by Vinod Khosla. It provides capital and strategic guidance to startups across stages, focusing on technology-driven companies in areas such as artificial intelligence, climate and sustainability, enterprise software and services, fintech, digital health, medical technology and diagnostics, therapeutics, consumer products, and frontier technologies. The firm backs bold ventures with the potential to disrupt markets and improve lives, supporting companies from early to growth stages and working closely with entrepreneurs to apply science, technology and innovative business models. While primarily investing in North American technology companies, Khosla Ventures pursues opportunities globally and emphasizes experimentation and impact alongside financial returns. The firm also maintains related impact initiatives that support entrepreneurs addressing socio-economic challenges in emerging markets.
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Mental Health
Marble Health
Seed Round in 2024
Marble Health provides access to personalized therapy to help teens in their mental health journey. Marble Health provides prompt and affordable care for middle and high school students experiencing common mental health issues such as anxiety, depression, and trauma. They ensure that all teens and their families can access treatment using their existing insurance coverage, including both commercial and Medicaid plans.
Limbic
Series A in 2024
Founded in London in 2017, Limbic specializes in developing software solutions for mental health. They create AI-driven agents to assist in patient intake, triage, screening, and therapy, aiming to enhance the efficiency of healthcare providers and improve patient outcomes.
Flow Neuroscience
Series A in 2021
Flow Neuroscience, established in 2011 and based in Malmö, Sweden, specializes in developing and manufacturing a wearable device and accompanying mobile application for medication-free treatment of depression. The company's core product is a transcranial direct current stimulation (tDCS) headset that targets the left frontal lobe, an area of the brain often associated with depression. This non-invasive treatment is complemented by a personalized mobile app that encourages users to adopt healthier daily routines, such as regular exercise and sleep patterns, to help alleviate depressive symptoms. Flow Neuroscience aims to make this innovative, affordable treatment accessible to the public, challenging the dominance of pharmaceuticals in mental health care.
Ellipsis Health
Series A in 2021
Founded in 2013, Ellipsis Health is a technology company that uses artificial intelligence to improve behavioral health. It analyzes patient speech and clinical data to predict health outcomes and provide real-time assessments for conditions like depression.
Yes Health
Series A in 2020
Yes Health designs a mobile application offering personalized nutrition, fitness, and diabetes-prevention advice. Its team of physicians, health coaches, and engineers creates engaging programs for users to adopt healthier lifestyles, prevent diabetes onset, and manage symptoms effectively.
Ginger
Series C in 2019
Ginger.io, Inc. is a digital mental health provider that offers a behavioral analytics platform designed to deliver on-demand mental healthcare via mobile devices. Founded in 2010 and headquartered in San Francisco, California, the platform connects users with a team of behavioral health coaches, therapists, and psychiatrists, facilitating personalized care accessible 24/7. Users can collect and analyze both passive and active behavioral data, enabling the identification of health insights and deviations from normal behavior. This service is utilized by a wide range of clients, including researchers, healthcare providers, and millions of employees through partnerships with leading employers and health plans. Ginger's approach focuses on providing immediate support and evidence-based interventions for individuals experiencing mental health challenges such as depression and anxiety.
Flow Neuroscience
Venture Round in 2019
Flow Neuroscience, established in 2011 and based in Malmö, Sweden, specializes in developing and manufacturing a wearable device and accompanying mobile application for medication-free treatment of depression. The company's core product is a transcranial direct current stimulation (tDCS) headset that targets the left frontal lobe, an area of the brain often associated with depression. This non-invasive treatment is complemented by a personalized mobile app that encourages users to adopt healthier daily routines, such as regular exercise and sleep patterns, to help alleviate depressive symptoms. Flow Neuroscience aims to make this innovative, affordable treatment accessible to the public, challenging the dominance of pharmaceuticals in mental health care.
Flow Neuroscience
Seed Round in 2018
Flow Neuroscience, established in 2011 and based in Malmö, Sweden, specializes in developing and manufacturing a wearable device and accompanying mobile application for medication-free treatment of depression. The company's core product is a transcranial direct current stimulation (tDCS) headset that targets the left frontal lobe, an area of the brain often associated with depression. This non-invasive treatment is complemented by a personalized mobile app that encourages users to adopt healthier daily routines, such as regular exercise and sleep patterns, to help alleviate depressive symptoms. Flow Neuroscience aims to make this innovative, affordable treatment accessible to the public, challenging the dominance of pharmaceuticals in mental health care.
Ellipsis Health
Seed Round in 2017
Founded in 2013, Ellipsis Health is a technology company that uses artificial intelligence to improve behavioral health. It analyzes patient speech and clinical data to predict health outcomes and provide real-time assessments for conditions like depression.
Vida Health
Series B in 2016
Vida Health is a virtual care platform focused on whole health by treating mental and physical conditions together. The platform combines an AI-powered, personalized experience with human coaches and therapists, offering video sessions, messaging, and digital content to help people prevent, manage, and reverse chronic conditions such as diabetes and hypertension, along with associated mental health conditions like stress, depression, and anxiety. The company serves large employers and health plans, providing access to clinicians including nutritionists, diabetes educators, nurses, trainers, and licensed therapists.
Thync
Series B in 2016
Thync, Inc. is a technology company based in Los Gatos, California, founded in 2011. The company specializes in developing wearable devices that leverage neurosignaling to facilitate transitions between different mental states, such as energy, calm, and focus. Drawing on expertise in neurobiology and neuroscience, Thync creates bioelectronic products aimed at enhancing mental well-being and addressing various consumer needs. Their innovative technology enables users to boost energy levels and improve mental clarity by directly activating specific nerves and neurons through neurostimulation patches. Thync's focus on the intersection of neuroscience and consumer electronics positions it as a pioneer in the field of wearable mental health technology.
Ginger
Series B in 2014
Ginger.io, Inc. is a digital mental health provider that offers a behavioral analytics platform designed to deliver on-demand mental healthcare via mobile devices. Founded in 2010 and headquartered in San Francisco, California, the platform connects users with a team of behavioral health coaches, therapists, and psychiatrists, facilitating personalized care accessible 24/7. Users can collect and analyze both passive and active behavioral data, enabling the identification of health insights and deviations from normal behavior. This service is utilized by a wide range of clients, including researchers, healthcare providers, and millions of employees through partnerships with leading employers and health plans. Ginger's approach focuses on providing immediate support and evidence-based interventions for individuals experiencing mental health challenges such as depression and anxiety.
Vida Health
Series A in 2014
Vida Health is a virtual care platform focused on whole health by treating mental and physical conditions together. The platform combines an AI-powered, personalized experience with human coaches and therapists, offering video sessions, messaging, and digital content to help people prevent, manage, and reverse chronic conditions such as diabetes and hypertension, along with associated mental health conditions like stress, depression, and anxiety. The company serves large employers and health plans, providing access to clinicians including nutritionists, diabetes educators, nurses, trainers, and licensed therapists.
Thync
Series A in 2014
Thync, Inc. is a technology company based in Los Gatos, California, founded in 2011. The company specializes in developing wearable devices that leverage neurosignaling to facilitate transitions between different mental states, such as energy, calm, and focus. Drawing on expertise in neurobiology and neuroscience, Thync creates bioelectronic products aimed at enhancing mental well-being and addressing various consumer needs. Their innovative technology enables users to boost energy levels and improve mental clarity by directly activating specific nerves and neurons through neurostimulation patches. Thync's focus on the intersection of neuroscience and consumer electronics positions it as a pioneer in the field of wearable mental health technology.
Ginger
Series A in 2012
Ginger.io, Inc. is a digital mental health provider that offers a behavioral analytics platform designed to deliver on-demand mental healthcare via mobile devices. Founded in 2010 and headquartered in San Francisco, California, the platform connects users with a team of behavioral health coaches, therapists, and psychiatrists, facilitating personalized care accessible 24/7. Users can collect and analyze both passive and active behavioral data, enabling the identification of health insights and deviations from normal behavior. This service is utilized by a wide range of clients, including researchers, healthcare providers, and millions of employees through partnerships with leading employers and health plans. Ginger's approach focuses on providing immediate support and evidence-based interventions for individuals experiencing mental health challenges such as depression and anxiety.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.